Mount Sinai cancer researchers to present several landmark studies at ASCO meeting

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago.

Dendreon loss narrows on modest Provenge sales

Dendreon Crop said on Monday that first-quarter sales of its Provenge prostate cancer vaccine rose 6.5 percent over the prior quarter to $82 million, and that it still expects only modest quarter-over-quarter ...